Improved survival following HLA-incompatible bone marrow transplantation. Munich Cooperative Group of Bone Marrow Transplantation

Folia Haematol Int Mag Klin Morphol Blutforsch. 1989;116(3-4):421-5.

Abstract

In most centers allogeneic bone marrow transplantation is restricted to patients with HLA-identical siblings as donors. We have transplanted 16 patients with marrow of donors other than HLA-identical siblings. Seven patients were grafted in the years 1978 until 1984. Six died of transplant complications and one of recurrent leukemia. More recently 9 patients were transplanted following an improved immunosuppressive conditioning treatment derived from experimental studies in dogs. Four are alive and in continuous remission between more than 2 months and 2 years. 5 patients died, 3 from fungal infections, one from recurrent leukaemia and one early from endothelial leakage syndrome. Our results indicate that intensified immunosuppressive conditioning may improve the results of marrow transplantation from HLA-haploidentical donors.

MeSH terms

  • Adolescent
  • Adult
  • Bone Marrow Transplantation / immunology*
  • Child
  • Female
  • Graft vs Host Disease / prevention & control
  • HLA Antigens / immunology*
  • Haplotypes
  • Histocompatibility / immunology*
  • Humans
  • Immunosuppression Therapy
  • Leukemia / surgery*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / surgery
  • Leukemia, Myeloid, Acute / surgery
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery

Substances

  • HLA Antigens